Trials / Completed
CompletedNCT07166783
Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
Pharmacokinetics, Pharmacological Effects and Safety of Single Dose of 7.5mg Tolvaptan Tablet in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Otsuka Beijing Research Institute · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Pharmacokinetics, pharmacological effects and safety of single dose of 7.5mg Tolvaptan tablet in healthy male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tolvaptan | single dose oral administration of 7.5mg Tolvaptan |
Timeline
- Start date
- 2011-06-16
- Primary completion
- 2011-07-04
- Completion
- 2011-07-04
- First posted
- 2025-09-10
- Last updated
- 2025-09-10
Source: ClinicalTrials.gov record NCT07166783. Inclusion in this directory is not an endorsement.